IFL SCIENCE | Two Revolutionary Non-Hormonal Male Birth Control Products Could Hit The Market In Two Years
ORIGINALLY POSTED ON: IFL SCIENCE
IFLScience met L.R. Fox of NEXT Life Sciences to learn about their latest promising clinical trial results for Plan A™ and PausePill™.
A “revolution” is coming. In as little as two years, I’m told, we could see a radical shift in the birth control landscape that will leave people of the future in mystified horror that we ever lived this way.
I’m meeting with L. R. Fox, Founder and Executive Chairman of NEXT Life Sciences, to talk male birth control. Fox is excitedly filling me in on the results of clinical trials for two different but complementary products.
If both progress through approval and reach the market as hoped, that would be quite the improvement from the current situation in contraceptive methods designed for the male reproductive system – condoms, a vasectomy, and... that's your lot.